You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR Phase II: Novel enzymes for producing homogeneous preparations of individual, monounsaturated industrial fatty acids

    SBC: VariFAS Biorenewables LLC            Topic: BT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development and scale-up of a manufacturing platform for producing bio-based chemicals for application in lubricants. This manufacturing platform will utilize biologically derived sugar carbon-source and transform this carbon to higher value products via microbial fermentation. In cont ...

    SBIR Phase II 2016 National Science Foundation
  2. Production of Image Guided Metastatic Melanoma Therapy Radiopharmaceuticals

    SBC: VIEWPOINT MOLECULAR TARGETING, INC.            Topic: 102

    DESCRIPTION provided by applicant Melanoma the fastest growing cancer incidence in the world today and the American Cancer Society reports that death rates for melanoma continue to rise Alarmingly melanoma is the most common cancer in young adults under One characteristic of metastatic melanoma cells that is recognized as a potential target for new therapies is upregulation of cell surfac ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy

    SBC: EMMYON, INC.            Topic: NIAMS

    DESCRIPTION provided by applicant Skeletal muscle atrophy is a highly prevalent condition caused by advanced age muscle disuse chronic illness critical illness and malnutrition In addition to being very common muscle atrophy has serious consequences including weakness reduced activity and quality of life falls fractures extended hospitalizatio and rehabilitation nursing home placem ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. The Noddle: A smart switch to enhance patient-provider communication.

    SBC: Iowa Adaptive Technologies, Inc.            Topic: 600

    DESCRIPTION provided by applicant Patients who cannot communicate with doctors nurses other health professionals and caregivers are at increased risk for having adverse medical outcomes Zubow and Hurtig reported that percent of conscious hospitalized patients and percent of intensive care unit patients were unable to independently activate standard nurse call systems Based on t ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Quantitative PCR Platform for The Assessment of Alcohol Consumption

    SBC: BEHAVIORAL DIAGNOSTICS, INC.            Topic: NIAAA

    DESCRIPTION provided by applicant Heavy alcohol use is common and presents a major social economic challenge Although chronic use of small amounts of alcohol is not always harmful heavier use andgt drinks day is generally harmful and frequently leads to alcoholism or as it is termed in ICD Alcohol Use Disorder AUD AUD affects of the U S population and causes over $ billio ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. STTR Phase I: Production of aromatic commodity chemicals via the coumalic acid platform using the catalyzed Diels-­‐Alder reaction in a continuous flow reactor

    SBC: SUSTEREA BIORENEWABLES LLC            Topic: CT

    The broader impact/commercial potential of this Small Business Technology Transfer Phase I project is the accelerated utilization of crop materials for the manufacture of biobased aromatic chemicals such as terephthalic acid and benzoic acid, which currently have global market value of $60 billion and $200 million, respectfully. This project focusses on benzoic acid (applications ranging from food ...

    STTR Phase I 2016 National Science Foundation
  7. SBIR Phase I: Stable Undercooled Metal Materials for Soldering Heat-Sensitive Components and Substrates

    SBC: Safi-tech, Inc.            Topic: MN

    This SBIR Phase I project will enable the use of flexible and printed electronic technologies for heat-sensitive materials such as plastics, papers, and organic electronics that cannot employ traditional soldering or conductive adhesives because of temperature, cost, and/or performance limitations. The foundation for the proposed research is a no-heat-added solder paste made from liquid-metal part ...

    SBIR Phase I 2016 National Science Foundation
  8. SBIR Phase I: Implantable Robotic System for Hearing Loss Treatment

    SBC: iotaMotion, Inc.            Topic: EW

    The broader impact/commercial potential of this project will be improved capabilities of current hearing assistive cochlear implants through the development of a miniature implantable robotic system. It will enable many more patients with hearing loss to retain their hearing capacity much longer over their lifetimes. Hearing loss has a significant impact on physical and mental health, education, e ...

    SBIR Phase I 2016 National Science Foundation
  9. SBIR Phase I: A game-based, cross-cutting physics and chemistry mobile application for grades 9-12

    SBC: Substrate Interactive, Inc.            Topic: EA

    This SBIR Phase I project will enable the development of a game-based, mobile cross-cutting physics and chemistry application for students in grades 9-12. In 2011 the National Research Council (NRC) published the final framework for the Next Generation Science Standards (NGSS). The NGSS, which have been adopted by 17 states and the District of Columbia, place an emphasis on cross-cutting science, ...

    SBIR Phase I 2016 National Science Foundation
  10. Precision, pulmonary disease evaluation and lung cancer detection using quantitative low-dose CT

    SBC: VIDA DIAGNOSTICS, INC.            Topic: 102

    DESCRIPTION provided by applicant Lung cancer is responsible for more cancer deaths than breast prostate and colon cancers combined Minimal improvements in the five year survival rate for lung cancer have occurred over the past thirty years Recently a mortality benefit has been demonstrated for lung cancer screening using low dose computed tomography LDCT in people with high cancer risk ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government